Which hedge funds own CAH? CARDINAL HEALTH INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
13 of the hedge funds tracked by WhaleCreep disclosed a position in CAH (CARDINAL HEALTH INC) in their Q2 2026 13F filings, worth $1.5bn in total. The largest holder by portfolio weight is WCM Investment Management at 1.3% of its book. 1 manager opened a new position this quarter: Glenview Capital Management. 2 exited: Farallon Capital Management, Holocene Advisors.
13tracked managers holding
1opened this quarter
2exited this quarter
Which hedge funds hold CAH? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| WCM Investment Management | Q2 2026 | 1.3% | $971.4m | 4,112,461 | 3% | added |
| Davidson Kempner Capital Management | Q2 2026 | 0.7% | $43.3m | 182,103 | 384% | added |
| Southeastern Asset Management | Q2 2026 | 0.4% | $1.7m | 7,337 | 0% | held |
| Brevan Howard Capital Management | Q2 2026 | 0.3% | $24.1m | 101,388 | 609% | added |
| Renaissance Technologies LLC | Q2 2026 | 0.2% | $130.7m | 550,100 | 60% | added |
| Bridgewater Associates | Q2 2026 | 0.1% | $31.4m | 132,077 | 15% | added |
| Glenview Capital Management | Q2 2026 | 0.1% | $4.3m | 18,018 | – | new |
| D. E. Shaw & Co | Q2 2026 | 0.1% | $130.7m | 550,261 | 51% | added |
| Marshall Wace | Q2 2026 | 0.0% | $55.9m | 235,305 | -56% | reduced |
| Millennium Management | Q2 2026 | 0.0% | $60.5m | 254,734 | -63% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $12.2m | 51,182 | -81% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $46.1m | 193,920 | -92% | reduced |
| Ancora Advisors | Q2 2026 | 0.0% | $94.1k | 396 | -12% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Farallon Capital Management | 3.2% | $77.8m |
| Holocene Advisors | 0.6% | $47.1m |
How has hedge fund ownership of CAH changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 13 | $1.5bn |
| Q1 2026 | 15 | $2.0bn |
| Q4 2025 | 9 | $1.5bn |
| Q3 2025 | 7 | $514.6m |
| Q2 2025 | 9 | $566.2m |
| Q1 2025 | 9 | $613.7m |
| Q4 2024 | 8 | $609.3m |
| Q3 2024 | 6 | $517.3m |
| Q2 2024 | 8 | $589.6m |
| Q1 2024 | 9 | $637.7m |
| Q4 2023 | 11 | $516.3m |
| Q3 2023 | 11 | $426.6m |
| Q2 2023 | 11 | $494.8m |
| Q1 2023 | 10 | $291.6m |
| Q4 2022 | 9 | $236.1m |
| Q3 2022 | 8 | $185.1m |
Counts every tracked manager that disclosed CAH in that quarter's filing, including managers that have since stopped filing.